MRV Engenharia e Participações (MRVE3) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
9 Jul, 2026Strategic review and lessons learned
Over 13 years in the U.S. market, the company completed 25 projects totaling 7,450 units and $1.2 billion in sales, experiencing both successful and challenging cycles, especially after pandemic-driven expansion.
The company matured by gaining local market knowledge and implementing a distinct, industrialized construction process, mainly in South Florida.
Utilizes concrete walls and off-site components to reduce labor needs and accelerate build times.
Strategic evolution and performance
Initial phase (2012-2019) focused on building a rental portfolio with gross margins above 30% and favorable cap rates; post-2020, the strategy shifted to developing properties for sale, requiring significant capital.
Projects completed in 2020-2022 delivered strong results (YoC 6.8%, Cap Rate 4.8%), but 2023-2024 projects saw lower YoC (4.7%) due to high interest rates and inflation.
Portfolio restructuring and divestment plan
A new management team and strategy were introduced at the end of 2023, focusing on recycling legacy properties and selling assets, even at a loss, to generate cash and deleverage.
The divestment plan targets ~$800 million in asset sales through 2026, with $117 million already sold and expected total cash generation of $493 million, reducing net debt by ~$365 million.
Four legacy projects remain for sale, with three expected to be stabilized by year-end; 11 additional land plots are being prepared for sale, all expected to be sold within two to three quarters.
Total impairment from asset and land sales is $144 million, with $81 million from land and $63 million from projects, recognized in 2Q25 for assets to be sold below cost.
Latest events from MRV Engenharia e Participações
- R$468.8 million in H1 cash generation and asset sales advanced deleveraging.MRVE3
Q2 2026 - Revenue grew, adjusted net profit reached R$133m, and cash generation totaled R$387m.MRVE3
Q1 2026 - Margin expansion, asset-light growth, and operational excellence drive improved results.MRVE3
Investor Day 2026 - Record margins and revenue growth, alongside cash pressures and Resia divestment.MRVE3
Q4 2025 - Q3 revenue and margins rose, while transfer delays constrained cash generation.MRVE3
Q3 2025 - Revenue and margins advanced, but transfer delays and Resia impairments weighed on cash and earnings.MRVE3
Q2 2025 - Record pre-sales and cash generation support a strong outlook despite US losses.MRVE3
Q3 2024 - Record R$2.539B pre-sales and 34% new-sales margin; Resia cash outflow persisted.MRVE3
Q2 2024 - Record pre-sales and cash recovery; Resia pivots to an US$800 million deleveraging plan.MRVE3
Q4 2024